Health Condition 1: O046- Delayed or excessive hemorrhage following (induced) termination of pregnancy
Conditions
Interventions
Intervention1: 0.03 mg of ethinylestradiol and 0.15 mg of desogestrel: Combined oral contraceptive once daily for three weeks (0.03 mg of ethinylestradiol and 0.15 mg of
desogestrel)
Control Interve
Sponsors
AIIMS, Guwahati
Eligibility
Inclusion criteria
Inclusion criteria: RPOC on TVS in patients where expectant management is indicated with positive urinary pregnancy test 1 with incomplete miscarriage 2 following medical abortion. 3 following surgical evacuation
Exclusion criteria
Exclusion criteria: RPOC with any of the following clinical presentations: 1 more than mild vaginal bleeding 2 haemodynamic instability 3 signs of infection and/ or abdominal pain 4 Contraindications for OCP use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of Participants With complete expulsion of RPOC at end of treatment as determined by TVSTimepoint: For Intervention group- Follow up at 4 weeks if no withdrawal bleeding or 1 week after withdrawal bleeding For control group- 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of participants requiring D and E at the end of treatment Timepoint: Intervention:4 weeks Control: 2 weeks;Percentage of participants with adverse effects (dizziness, weakness, vomiting, pain abdomen, signs of infection) Timepoint: Intervention: 4weeks Control: 2 weeks | — |
Countries
India
Contacts
Public ContactDr Dibyajyoti Saikia
AllMS, Guwahati
Outcome results
None listed